Literature DB >> 15131269

The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-alpha/beta-induced ubiquitin-like protein.

Chen Zhao1, Sylvie L Beaudenon, Melissa L Kelley, M Brett Waddell, Weiming Yuan, Brenda A Schulman, Jon M Huibregtse, Robert M Krug.   

Abstract

Ubiquitin-(Ub) like proteins (Ubls) are conjugated to their targets by an enzymatic cascade involving an E1 activating enzyme, an E2 conjugating enzyme, and in some cases an E3 ligase. ISG15 is a Ubl that is conjugated to cellular proteins after IFN-alpha/beta stimulation. Although the E1 enzyme for ISG15 (Ube1L/E1(ISG15)) has been identified, the identities of the downstream components of the ISG15 conjugation cascade have remained elusive. Here we report the purification of an E2 enzyme for ISG15 and demonstrate that it is UbcH8, an E2 that also functions in Ub conjugation. In vitro assays with purified Ub E2 enzymes and in vivo RNA interference assays indicate that UbcH8 is a major E2 enzyme for ISG15 conjugation. These results indicate that the ISG15 conjugation pathway overlaps or converges with the Ub conjugation pathway at the level of a specific E2 enzyme. Furthermore, these results raise the possibility that the ISG15 conjugation pathway might use UbcH8-competent Ub ligases in vivo. As an initial test of this hypothesis, we have shown that a UbcH8-competent Ub ligase conjugates ISG15 to a specific target in vitro. These results challenge the concept that Ub and Ubl conjugation pathways are strictly parallel and nonoverlapping and have important implications for understanding the regulation and function of ISG15 conjugation in the IFN-alpha/beta response.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15131269      PMCID: PMC419648          DOI: 10.1073/pnas.0402528101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

Review 1.  The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion.

Authors:  D E Levy; A García-Sastre
Journal:  Cytokine Growth Factor Rev       Date:  2001 Jun-Sep       Impact factor: 7.638

Review 2.  SUMO, ubiquitin's mysterious cousin.

Authors:  S Müller; C Hoege; G Pyrowolakis; S Jentsch
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 3.  Themes and variations on ubiquitylation.

Authors:  A M Weissman
Journal:  Nat Rev Mol Cell Biol       Date:  2001-03       Impact factor: 94.444

Review 4.  F-box proteins and protein degradation: an emerging theme in cellular regulation.

Authors:  J C del Pozo; M Estelle
Journal:  Plant Mol Biol       Date:  2000-09       Impact factor: 4.076

Review 5.  A new RING for SUMO: wrestling transcriptional responses into nuclear bodies with PIAS family E3 SUMO ligases.

Authors:  P K Jackson
Journal:  Genes Dev       Date:  2001-12-01       Impact factor: 11.361

Review 6.  Parkin is linked to the ubiquitin pathway.

Authors:  K Tanaka; T Suzuki; T Chiba; H Shimura; N Hattori; Y Mizuno
Journal:  J Mol Med (Berl)       Date:  2001-09       Impact factor: 4.599

Review 7.  Mechanisms underlying ubiquitination.

Authors:  C M Pickart
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

8.  Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein.

Authors:  W Yuan; R M Krug
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

9.  Structure of a conjugating enzyme-ubiquitin thiolester intermediate reveals a novel role for the ubiquitin tail.

Authors:  K S Hamilton; M J Ellison; K R Barber; R S Williams; J T Huzil; S McKenna; C Ptak; M Glover; G S Shaw
Journal:  Structure       Date:  2001-10       Impact factor: 5.006

10.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

View more
  143 in total

1.  E1-E2 interactions in ubiquitin and Nedd8 ligation pathways.

Authors:  Zeynep Tokgöz; Thomas J Siepmann; Frederick Streich; Brajesh Kumar; Jennifer M Klein; Arthur L Haas
Journal:  J Biol Chem       Date:  2011-11-08       Impact factor: 5.157

2.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

3.  Up-regulation of interferon-stimulated gene15 and its conjugates by tumor necrosis factor-α via type I interferon-dependent and -independent pathways.

Authors:  Kongthawat Chairatvit; Ariyaphong Wongnoppavich; Sirinthip Choonate
Journal:  Mol Cell Biochem       Date:  2012-06-23       Impact factor: 3.396

4.  Type I interferon related genes are common genes on the early stage after vaccination by meta-analysis of microarray data.

Authors:  Junnan Zhang; Jie Shao; Xing Wu; Qunying Mao; Yiping Wang; Fan Gao; Wei Kong; Zhenglun Liang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

5.  ISG15 Arg151 and the ISG15-conjugating enzyme UbE1L are important for innate immune control of Sindbis virus.

Authors:  Nadia V Giannakopoulos; Elena Arutyunova; Caroline Lai; Deborah J Lenschow; Arthur L Haas; Herbert Whiting Virgin
Journal:  J Virol       Date:  2008-12-10       Impact factor: 5.103

6.  Interferon-inducible ubiquitin E2, Ubc8, is a conjugating enzyme for protein ISGylation.

Authors:  Keun Il Kim; Nadia V Giannakopoulos; Herbert W Virgin; Dong-Er Zhang
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

7.  The Spen homolog Msx2-interacting nuclear target protein interacts with the E2 ubiquitin-conjugating enzyme UbcH8.

Authors:  Junfeng Li; Jishu Wang; Xi Yang; Junlin Li; Hongyan Qin; Xiao Dong; Yangting Zhu; Liang Liang; Yingmin Liang; Hua Han
Journal:  Mol Cell Biochem       Date:  2006-04-01       Impact factor: 3.396

8.  UBE1L causes lung cancer growth suppression by targeting cyclin D1.

Authors:  Qing Feng; David Sekula; Yongli Guo; Xi Liu; Candice C Black; Fabrizio Galimberti; Sumit J Shah; Lorenzo F Sempere; Vincent Memoli; Jesper B Andersen; Bret A Hassel; Konstantin Dragnev; Ethan Dmitrovsky
Journal:  Mol Cancer Ther       Date:  2008-12       Impact factor: 6.261

9.  Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation.

Authors:  Fumihiko Okumura; Akiko J Okumura; Keiji Uematsu; Shigetsugu Hatakeyama; Dong-Er Zhang; Takumi Kamura
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  ISG15 as a novel tumor biomarker for drug sensitivity.

Authors:  Shyamal D Desai; Laurence M Wood; Yu-Chen Tsai; Tao-Shih Hsieh; Jeffrey R Marks; Georgia L Scott; Beppino C Giovanella; Leroy F Liu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.